TransCode Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RNAZ)

CUSIP: 89357L402

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class
Equity / Common Stock, $0.0001 par value per share
Total 13F shares
0
Total 13F value
$0
Holder snapshot 5 signals
Share change
-2,128,495
SEC-reported price per share
$0.35
Number of holders
0
Value change
-$1,053,827
Number of sells
15
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,028,000

Security key

89357L402

Report period

Q2 2025

Institutions

0

Top holders

0

RNAZ full security history Previous quarter: Q1 2025 Transcode Therapeutics, Inc. SEC filings Transcode Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

There are no holders of RNAZ - TransCode Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .